BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34447366)

  • 1. Oral Fc-Coupled Preproinsulin Achieves Systemic and Thymic Delivery Through the Neonatal Fc Receptor and Partially Delays Autoimmune Diabetes.
    Corcos N; Culina S; Deligne C; Lavaud C; You S; Mallone R
    Front Immunol; 2021; 12():616215. PubMed ID: 34447366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Materno-Fetal Transfer of Preproinsulin Through the Neonatal Fc Receptor Prevents Autoimmune Diabetes.
    Culina S; Gupta N; Boisgard R; Afonso G; Gagnerault MC; Dimitrov J; Østerbye T; Justesen S; Luce S; Attias M; Kyewski B; Buus S; Wong FS; Lacroix-Desmazes S; Mallone R
    Diabetes; 2015 Oct; 64(10):3532-42. PubMed ID: 25918233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the neonatal fc receptor for antigen delivery using engineered fc fragments.
    Mi W; Wanjie S; Lo ST; Gan Z; Pickl-Herk B; Ober RJ; Ward ES
    J Immunol; 2008 Dec; 181(11):7550-61. PubMed ID: 19017944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of antigen to intestinal dendritic cells induces oral tolerance and prevents autoimmune diabetes in NOD mice.
    Chen Y; Wu J; Wang J; Zhang W; Xu B; Xu X; Zong L
    Diabetologia; 2018 Jun; 61(6):1384-1396. PubMed ID: 29546475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting Salmonella-based combination immunotherapy for prevention of type 1 diabetes in non-obese diabetic mice.
    Husseiny MI; Du W; Mbongue J; Lenz A; Rawson J; Kandeel F; Ferreri K
    Vaccine; 2018 Dec; 36(52):8008-8018. PubMed ID: 30416020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic expression of mutated B16:A preproinsulin messenger RNA does not reverse acceleration of NOD diabetes associated with insulin 2 (thymic expressed insulin) knockout.
    Nakayama M; Babaya N; Miao D; Sikora K; Elliott JF; Eisenbarth GS
    J Autoimmun; 2005 Nov; 25(3):193-8. PubMed ID: 16289958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering.
    Wang Y; Tian Z; Thirumalai D; Zhang X
    J Drug Target; 2014 May; 22(4):269-78. PubMed ID: 24404896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient mucosal vaccination mediated by the neonatal Fc receptor.
    Ye L; Zeng R; Bai Y; Roopenian DC; Zhu X
    Nat Biotechnol; 2011 Feb; 29(2):158-63. PubMed ID: 21240266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
    Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
    Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a label-free FcRn-mediated transcytosis assay for in vitro characterization of FcRn interactions with therapeutic antibodies and Fc-fusion proteins.
    Chung S; Lin YL; Nguyen V; Kamen L; Zheng K; Vora B; Song A
    J Immunol Methods; 2018 Nov; 462():101-105. PubMed ID: 30030147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal Fc receptor FcRn is involved in intracellular transport of the Fc fusion protein aflibercept and its transition through retinal endothelial cells.
    Deissler HL; Lang GK; Lang GE
    Exp Eye Res; 2017 Jan; 154():39-46. PubMed ID: 27836572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy.
    Chen P; Li C; Lang S; Zhu G; Reheman A; Spring CM; Freedman J; Ni H
    Blood; 2010 Nov; 116(18):3660-8. PubMed ID: 20647570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptor.
    Burvenich IJ; Farrugia W; Lee FT; Catimel B; Liu Z; Makris D; Cao D; O'Keefe GJ; Brechbiel MW; King D; Spirkoska V; Allan LC; Ramsland PA; Scott AM
    MAbs; 2016; 8(4):775-86. PubMed ID: 27030023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance.
    Mimoun A; Delignat S; Peyron I; Daventure V; Lecerf M; Dimitrov JD; Kaveri SV; Bayry J; Lacroix-Desmazes S
    Front Immunol; 2020; 11():810. PubMed ID: 32477339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
    Maron R; Guerau-de-Arellano M; Zhang X; Weiner HL
    J Autoimmun; 2001 Feb; 16(1):21-8. PubMed ID: 11221993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics.
    Piche-Nicholas NM; Avery LB; King AC; Kavosi M; Wang M; O'Hara DM; Tchistiakova L; Katragadda M
    MAbs; 2018 Jan; 10(1):81-94. PubMed ID: 28991504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery.
    Pridgen EM; Alexis F; Kuo TT; Levy-Nissenbaum E; Karnik R; Blumberg RS; Langer R; Farokhzad OC
    Sci Transl Med; 2013 Nov; 5(213):213ra167. PubMed ID: 24285486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration.
    Smith B; Kiessling A; Lledo-Garcia R; Dixon KL; Christodoulou L; Catley MC; Atherfold P; D'Hooghe LE; Finney H; Greenslade K; Hailu H; Kevorkian L; Lightwood D; Meier C; Munro R; Qureshi O; Sarkar K; Shaw SP; Tewari R; Turner A; Tyson K; West S; Shaw S; Brennan FR
    MAbs; 2018 Oct; 10(7):1111-1130. PubMed ID: 30130439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin2 gene (Ins2) transcription by NOD bone marrow-derived cells does not influence autoimmune diabetes development in NOD-Ins2 knockout mice.
    Martin-Pagola A; Pileggi A; Zahr E; Vendrame F; Damaris Molano R; Snowhite I; Ricordi C; Eisenbarth GS; Nakayama M; Pugliese A
    Scand J Immunol; 2009 Nov; 70(5):439-46. PubMed ID: 19874548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues.
    Andersen JT; Justesen S; Fleckenstein B; Michaelsen TE; Berntzen G; Kenanova VE; Daba MB; Lauvrak V; Buus S; Sandlie I
    FEBS J; 2008 Aug; 275(16):4097-110. PubMed ID: 18637944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.